Angiotensin II receptor antagonists against migraine in pregnancy: Fatal outcome

Journal of Headache and Pain

Volumn 11, Issue 2, 2010, Pages 167-169

  Haaland, Kirsti ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angiotensin II receptor antagonist; Angiotensin converting enzyme inhibitor; Fetotoxic medication; Hypertension; Migraine; Pregnancy

Indexed keywords

AMITRIPTYLINE; CANDESARTAN; METOCLOPRAMIDE; PRAMIPEXOLE; ZOLMITRIPTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TERATOGENIC AGENT; TETRAZOLE DERIVATIVE;

ADULT; ANHYDRAMNIOS; ARTICLE; CASE REPORT; DISEASE SEVERITY; FEMALE; FETUS; FETUS MALFORMATION; HUMAN; HYALINE MEMBRANE DISEASE; KIDNEY MALFORMATION; KIDNEY TUBULE DISORDER; LUNG HYPOPLASIA; MIGRAINE; MISSED ABORTION; NAUSEA; NEWBORN; PHOTOPHOBIA; PREGNANCY; PREGNANCY DISORDER; PREGNANT WOMAN; PRIORITY JOURNAL; SCOTOMA; SKULL MALFORMATION; VOMITING; CONGENITAL MALFORMATION; DRUG EFFECT; FATALITY; KIDNEY; LUNG; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PLACENTA; SKULL;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; FATAL OUTCOME; FEMALE; FETUS; HUMANS; KIDNEY; LUNG; MALE; MIGRAINE DISORDERS; PLACENTA; PREGNANCY; SKULL; TERATOGENS; TETRAZOLES;

EID: 77953465542     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-009-0182-7     Document Type: Article

References (17)

1. Kato K, Okuda M, Ishikawa H, Takahashi T, Hirahara F (2008) Oligohydramnios and pulmonary hypoplasia: a case in which involvement of an angiotensin II receptor antagonist was suspected. J Obstet Gynaecol Res 34(2):242-246.
2. Serreau R, Luton D, Macher MA, Delezoide AL, Garel C, Jacqz-Aigrain E (2005) Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of ten cases. BJOG 112(6):710-712.
3. Regional medicines information centres. Norwegian database of adverse effects.
4. Ramadan NM (2007) Current trends in migraine prophylaxis. Headache 47(Suppl 1):S52-S57.
5. Lacoste M, Cai Y, Guicharnaud L et al (2006) Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: role of the renin-angiotensin system. J Am Soc Nephrol 17(8):2253-2263.
6. Norwegian Medicines Agency. Summary of product characteristics (SPC), Atacand.
7. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G (2003) Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 289(1):65-69.
8. Schrader H, Stovner LJ, Helde G, Sand T, Bovim G (2001) Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ 322(7277):19-22.
9. Etminan M, Levine MA, Tomlinson G, Rochon PA (2002) Efficacy of angiotensin II receptor antagonists in preventing headache: a systematic overview and meta-analysis. Am J Med 112(8):642-646.
10. Bender WI (1995) ACE inhibitors for prophylaxis of migraine headaches. Headache 35(8):470-471.
11. Owada K (2004) Efficacy of candesartan in the treatment of migraine in hypertensive patients. Hypertens Res 27(6):441-446.
12. Silberstein SD (2000) Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55(6):754-762.
13. Evers S, Afra J, Frese A et al (2006) EFNS guideline on the drug treatment of migraine-report of an EFNS task force. Eur J Neurol 13(6):560-572.
14. Modi S, Lowder DM (2006) Medications for migraine prophylaxis. Am Fam Phys 73(1):72-78.
15. Stark RJ, Stark CD (2008) Migraine prophylaxis. Med J Aust 189(5):283-288.
16. Sanchez SI, Seltzer AM, Fuentes LB, Forneris ML, Ciuffo GM (2008) Inhibition of Angiotensin II receptors during pregnancy induces malformations in developing rat kidney. Eur J Pharmacol 588(1):114-123.
17. Guron G, Sundelien B, Wickman A, Friberg P (1988) Angiotensin-converting enzyme inhibition in piglets induces persistent renal abnormalities. Clin Exp Pharmacol Physio 25(2):88-91.